[1]
R. A. Wess, T. Schmidt, and S. Höger, “Challenges of Regulatory Environmental Risk Assessment for Human Pharmaceuticals with Focus on Antibiotics”, Chimia, vol. 74, no. 3, p. 183, Mar. 2020.